The safety of Abatacept in patients with active rheumatoid arthritis and insufficient response to an anti-TNF treatment: Results of the ARRIVE study

被引：0
|
作者：
Rieger, H. J.
Schiff, M.
Pritchard, C.
Teng, J.
Bahrt, K.
Genovese, M.
机构：
[1] Bristol Myers Squibb Co, Munich, Germany
[2] Denver Arthritis Clin, Denver, CO USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Stanford Univ, Palo Alto, CA 94304 USA
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [1] The safety of abatacept in patients with active rheumatoid arthritis and an inadequate response to anti-TNF therapy: Results from the arrive trial
    Schiff, M.
    Pritchard, C.
    Teng, J.
    Bahrt, K.
    Genovese, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 89 - 89
  • [2] The efficacy and safety of abatacept in patients with active rheumatoid arthritis and an inadequate response to anti-TNF therapy: Results from the arrive trial
    Emery, P.
    Pritchard, C.
    Zhou, X.
    Genovese, M.
    Schiff, M.
    [J]. RHEUMATOLOGY, 2008, 47 : II45 - II45
  • [3] Response to pneumococcal vaccine in rheumatoid arthritis patients with an inadequate response to anti-TNF therapy treated with abatacept in the arrive trial
    Schiff, M.
    Kaell, A.
    Tay, L.
    Vratsanos, G.
    Bahrt, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 437 - 437
  • [4] Identification of cartilage oligomeric matrix protein as biomarker predicting abatacept response in rheumatoid arthritis patients with insufficient response to a first anti-TNFα treatment
    Minh Vu Chuong Nguyen
    Adrait, Annie
    Baillet, Athan
    Trocme, Candice
    Gottenberg, Jacques-Eric
    Gaudin, Philippe
    [J]. JOINT BONE SPINE, 2019, 86 (03) : 401 - 403
  • [5] Predicting response to anti-TNF treatment in rheumatoid arthritis patients
    Atzeni, Fabiola
    Antivalle, Marco
    Pallavicini, Francesca Bobbio
    Caporali, Roberto
    Bazzani, Chiara
    Gorla, Roberto
    Favalli, Ennio Giulio
    Marchesoni, Antonio
    Sarzi-Puttini, Piercarlo
    [J]. AUTOIMMUNITY REVIEWS, 2009, 8 (05) : 431 - 437
  • [6] Rheumatoid factor as predictor of response to treatment with anti-TNF alpha drugs in patients with rheumatoid arthritis Results of a cohort study
    Santos-Moreno, Pedro
    Sanchez, Guillermo
    Castro, Carlos
    [J]. MEDICINE, 2019, 98 (05)
  • [7] Abatacept has beneficial effects in rheumatoid arthritis patients with an inadequate response to anti-TNFα therapy
    Genovese, MC
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (06) : 767 - 768
  • [8] COST-UTILITY OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INSUFFICIENT RESPONSE OR INTOLERANCE TO ANTI-TNF THERAPY IN ITALY: A PROBABILISTIC SENSITIVITY ANALYSIS
    Mantovani, L. G.
    De Portu, S.
    Intorcia, M.
    Olivieri, I
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A548 - A548
  • [9] Pharmacogenomics of anti-TNF treatment in rheumatoid arthritis reveals an active baseline TNF response profile in all patients
    van Baarsenl, Lisa G. M.
    Wijbrandts, Carla A.
    Rustenburg, Frarncois
    Kraan, Tineke C. T. M. Van der Pouw
    Dijkmans, Ben A. C.
    Tak, Paul P.
    Verweij, Comelis L.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S776 - S777
  • [10] Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis
    Coenen, Marieke J. H.
    Toonen, Erik J. M.
    Scheffer, Hans
    Radstake, Timothy R. D. J.
    Barrera, Pilar
    Franke, Barbara
    [J]. PHARMACOGENOMICS, 2007, 8 (07) : 761 - 773
12345